SPRO
Spero Therapeutics Inc
$1.41
Earnings Summary
Revenue | $71.83Mn |
Net Profits | $51.19Mn |
Net Profit Margins | 71.27% |
Highlights
Spero Therapeutics Inc’s revenue jumped 55.13% since last year same period to $71.83Mn in the Q4 2023. On a quarterly growth basis, Spero Therapeutics Inc has generated 181.97% jump in its revenue since last 3-months.
Spero Therapeutics Inc’s net profit jumped 91.22% since last year same period to $51.19Mn in the Q4 2023. On a quarterly growth basis, Spero Therapeutics Inc has generated 1697.22% jump in its net profits since last 3-months.
Spero Therapeutics Inc’s net profit margin jumped 23.26% since last year same period to 71.27% in the Q4 2023. On a quarterly growth basis, Spero Therapeutics Inc has generated 666.45% jump in its net profit margins since last 3-months.
Earnings per share (EPS) Estimates
Earnings per share (EPS) estimates of the Spero Therapeutics Inc post its latest quarter earnings
EPS Estimate Current Quarter | -0.04 |
EPS Estimate Current Year | -0.04 |
Highlights
Spero Therapeutics Inc’s earning per share (EPS) estimates for the current quarter stand at -0.04 - a 60% jump from last quarter’s estimates.
Spero Therapeutics Inc’s earning per share (EPS) estimates for the current year stand at -0.04.
Key Ratios
Key ratios of the Spero Therapeutics Inc post its Q4 2023 earnings
Earning Per Share (EPS) | 0.96 |
Highlights
Spero Therapeutics Inc’s earning per share (EPS) jumped 74.55% since last year same period to 0.96 in the Q4 2023. This indicates that the Spero Therapeutics Inc has generated 74.55% annual rate of jump in its earning per share (EPS) in the last 4 quarters.
Earnings Calendar
| Earnings Date | Estimated EPS | Reported EPS | Surprise % |
|---|---|---|---|
2023-08-10 | -0.34 | -0.23 | 32.35% |
2024-03-13 | -0.1 | 0.96 | 1060% |
2023-11-13 | -0.03 | 0.04 | 233.33% |
2023-05-11 | -0.33 | -0.25 | 24.24% |
₹0 US Stocks a/c Opening Fee